Learning Optimal Dynamic Treatment Regime From Observational Clinical Data Through Reinforcement Learning. Physicians & academicsPublication

July 28, 2024

Learning Optimal Dynamic Treatment Regime From Observational Clinical Data Through Reinforcement Learning.

Abebe S,  Poli I ,  Jones RD and Slanzi D. Mach. In: Learn. Knowl. Extr.…

Susanne

Love0

Lack of Adherence Increases Cardiovascular Risks in Diabetes. Article in the ‘Österreichische Ärztezeitung’ For the public & patientsPhysicians & academics

July 17, 2024

Lack of Adherence Increases Cardiovascular Risks in Diabetes. Article in the ‘Österreichische Ärztezeitung’

According to a new study of the Medical University of Innsbruck, a lack of adherence…

Susanne

Love0

Diabetics With Low Treatment Adherence Have a Poor Prognosis. Austrian Press Release from April 30, 2024 For the public & patientsPhysicians & academics

May 14, 2024

Diabetics With Low Treatment Adherence Have a Poor Prognosis. Austrian Press Release from April 30, 2024

People with type 2 diabetes should pay attention to their blood sugar levels and keep…

Susanne

Love0

The Importance of Taking Medication for Diabetes. Austrian Press Release from April 27, 2024 For the public & patientsPhysicians & academics

May 14, 2024

The Importance of Taking Medication for Diabetes. Austrian Press Release from April 27, 2024

For diabetes patients it is important to adhere to the prescribed medication. This was recently…

Susanne

Love0

Public Perspective on Personalized Medicine: A Survey of Public and Patients Opinion For the public & patientsPhysicians & academics

April 10, 2024

Public Perspective on Personalized Medicine: A Survey of Public and Patients Opinion

The DC-ren partner Medical University Innsbruck, Department of Internal Medicine IV,Nephrology and Hypertension has compiled…

Susanne

Love0

Clustering Trajectories to Study Diabetic Kidney Disease Physicians & academicsPublication

April 9, 2024

Clustering Trajectories to Study Diabetic Kidney Disease

Distefano V, Mannone M, Poli I, Mayer G. In: Villani, M., Cagnoni, S., Serra, R.…

Susanne

Love0

Exploiting the Potential of Bayesian Networks in Deriving New Insight into Diabetic Kidney Disease (DKD) Physicians & academicsPublication

April 4, 2024

Exploiting the Potential of Bayesian Networks in Deriving New Insight into Diabetic Kidney Disease (DKD)

Slanzi D, Silvestri C, Poli, I, Mayer G. In: Villani, M., Cagnoni, S., Serra, R.…

Susanne

Love0

Justyna Siwy is the new PI of the DC-ren partner mosaiques diagnostics GmbH For the public & patientsPhysicians & academics

March 12, 2024

Justyna Siwy is the new PI of the DC-ren partner mosaiques diagnostics GmbH

Justyna Siwy succeeded Harald Mischak and took over the areas of the DC-ren project management…

Susanne

Love0

Early detection of kidney diseases. Live interview on the Austrian radio station OE1 with the nephrologists Gert Mayer and Marcus Säemann For the public & patients

March 6, 2024

Early detection of kidney diseases. Live interview on the Austrian radio station OE1 with the nephrologists Gert Mayer and Marcus Säemann

What are the risk factors for kidney disease? How can kidney weakness be detected early…

Susanne

Love0

Chronically ill: can a urine test save the healthcare system from collapse? For the public & patientsPhysicians & academics

March 4, 2024

Chronically ill: can a urine test save the healthcare system from collapse?

A German health insurance company sponsors a urine test for its customers to prevent cancer…

Susanne

Love0

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease Physicians & academics

February 19, 2024

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease

Tarunveer S. Ahluwalia, Teemu K.E. Rönkkö, Mie K. Eickhoff, Viktor Rotbain Curovic, Justyna Siwy, Susanne…

Susanne

Love0

The DC-ren partner mosaiques diagnostics provides highly innovative Clinical Proteomics services for academic institutions and pharmaceutical companies For the public & patientsPhysicians & academics

February 12, 2024

The DC-ren partner mosaiques diagnostics provides highly innovative Clinical Proteomics services for academic institutions and pharmaceutical companies

First health insurance company in Germany pays for luxury urine test. Hope for kidney patients.…

Susanne

Love0

DC-ren project status For the public & patientsPhysicians & academics

December 31, 2023

DC-ren project status

The second periodic report is completed and DC-ren met all major project milestones.

Christof Simon

Love0

Context and overall objectives of the project. For the public & patientsPhysicians & academics

December 29, 2023

Context and overall objectives of the project.

Diabetic Kidney Disease (DKD) is a serious clinical condition, and the incidence increases in parallel…

Christof Simon

Love0

For the public & patients

December 22, 2023

Drug combinatinos for re-writing trajectories of renal pathologies in type II diabetes

Christof Simon

Love0

For the public & patients

December 22, 2023

Big data and precision medicine

Christof Simon

Love0

For the public & patients

December 18, 2023

Why do we need precision medicine? What about inter-, and most of intraindividual heterogeneity in DKD? A video with Arno Lukas from EMTEC

Why do we need precision medicine? What about inter-, and most of intraindividual heterogeneity in…

Diana Derias

Love0

For the public & patients

December 18, 2023

Why do we need multidisciplinary team to solve the problem and what are the challenges that come with that? A video with Irene Poli from UNIVE

Diana Derias

Love0

For the public & patients

December 18, 2023

Why is diabetic kidney disease an important problem in Europe? A video with Sara Denicolo from The Medical University of Innsbruck

Why is diabetic kidney disease an important problem in Europe? What is the current approach…

Diana Derias

Love0

DC-ren associated studies Industry & stakeholdersPhysicians & academics

December 14, 2023

DC-ren associated studies

The concept of precision medicine as proposed by DC-ren is also of great interest to…

Christof Simon

Love0

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease. Physicians & academics

November 29, 2023

Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease.

Ahluwalia  TS, Rönkkö TKE,  Eickhoff MK, Curovic VR, Siwy J, Eder S, Denicolò S, Mayer…

Christof Simon

Love0

DC-ren GENERAL ASSEMBLY 2023 For the public & patientsIndustry & stakeholders

November 20, 2023

DC-ren GENERAL ASSEMBLY 2023

Members of the DC-ren consortium, convened for the meeting at the AC Hotel in Innsbruck,…

Christof Simon

Love0

Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes. Physicians & academics

November 17, 2023

Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes.

Møller AL, Thöni S, Keller F, Sharifli S, Rasmussen DGK, Genovese F, Karsdal MA, Mayer…

Christof Simon

Love0

Candidate composite biomarker to inform drug treatments for diabetic kidney disease. Physicians & academics

November 1, 2023

Candidate composite biomarker to inform drug treatments for diabetic kidney disease.

Jones RD, Abebe S, Distefano V, Mayer G, Poli I, Silvestri C, Slanzi D.Front Med…

Christof Simon

Love0

Physicians & academics

October 31, 2023

Urinary peptide analysis to predict the response to blood pressure medication

Jaimes Campos MA, Mavrogeorgis E, Latosinska A, Eder S, Buchwinkler L, Mischak H, Siwy J,…

Diana Derias

Love0

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study. Physicians & academics

September 14, 2023

Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.

Jaimes Campos MA, Andújar I, Keller F, Mayer G, Rossing P, Staessen JA, Delles C,…

Christof Simon

Love0

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment. Physicians & academics

August 31, 2023

Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment.

Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thöni S, Mayer G, Mischak H, Vlahou…

Christof Simon

Love0

Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patients Physicians & academics

June 6, 2023

Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patients

Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thoeni S, Mayer G, Mischak H, Vlahou…

Christof Simon

Love0

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial. Physicians & academics

April 4, 2023

Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria – A post-hoc analysis of the PRIORITY randomized clinical trial.

Curovic VR, Tofte N, Lindhardt M, Adamova K,  Bakker SJL, Beige J, Beulens JWJ, Birkenfeld…

Christof Simon

Love0

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis. Physicians & academics

December 31, 2022

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis.

Denicolò S, Nair V, Leierer J, Rudnicki M, Kretzler M, Mayer G, Ju W, Perco…

Christof Simon

Love0